Unveiling novel drug targets for atherosclerosis: A Mendelian randomization analysis
Open Access
- 22 May 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (21) , e48919
Abstract
Atherosclerosis is a leading cause of cardiovascular diseases, necessitating the identification of novel therapeutic targets. By utilizing Mendelian randomization, the aim is to identify potential drug targets for the treatment of atherosclerosis. Using results from genomewide association studies and protein quantitative trait loci data, we genetically identified causal effects of levels of several circulating proteins on atherosclerosis risk, validated using multiple statistical approaches, and identified promising drug targets. These findings demonstrated promising targets worthy of further clinical study, especially lipoprotein (a) and proprotein convertase subtilisin/kexin type 9.Keywords
This publication has 59 references indexed in Scilit:
- Endothelial dysfunction: molecular mechanisms and clinical implicationsMedcomm, 2024
- APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillariesJournal of Lipid Research, 2024
- Targeting PCSK9 to tackle cardiovascular diseasePharmacology & Therapeutics, 2023
- Human genetics evidence supports two-thirds of the 2021 FDA-approved drugsNature Reviews Drug Discovery, 2022
- Pathway analysis of GWAS loci identifies novel drug targets and repurposing opportunitiesDrug Discovery Today, 2019
- Connecting genetic risk to disease end points through the human blood plasma proteomeNature Communications, 2017
- A Test in Context: Lipoprotein(a)JACC, 2017
- Plasma Proprotein Convertase Subtilisin Kexin Type 9 as a Predictor of Carotid Atherosclerosis in Asymptomatic AdultsHeart, Lung and Circulation, 2016
- The support of human genetic evidence for approved drug indicationsNature Genetics, 2015
- Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian populationMolecular and Cellular Probes, 2015